Nicholas Wragg n.wragg1@keele.ac.uk
Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device
Wragg, Nicholas
Authors
Abstract
Hemophilia A (HA) is a rare bleeding disorder caused by deficiency/dysfunction of the FVIII protein. As current therapies based on frequent FVIII infusions are not a definitive cure, long-term expression of FVIII in endothelial cells through lentiviral vector (LV)-mediated gene transfer holds the promise of a one-time treatment. Thus, here we sought to determine whether LV-corrected blood outgrowth endothelial cells (BOECs) implanted through a prevascularized medical device (Cell Pouch™) would rescue the bleeding phenotype of HA mice. To this end, BOECs from HA patients and healthy donors were isolated, expanded and transduced with an LV carrying FVIII driven by an endothelial-specific promoter employing GMP-like procedures. FVIII-corrected HA-BOECs were either directly transplanted into the peritoneal cavity or injected into a Cell Pouch™ implanted subcutaneously in NSG-HA mice. In both cases, FVIII secretion sufficient to improve the mouse bleeding phenotype. Indeed, FVIII-corrected HA-BOECs reached a relatively short-term clinically relevant engraftment being detected up to 16 weeks after transplantation, and their genomic integration profile did not show enrichment for oncogenes, confirming the process safety. Overall, this is the first pre-clinical study showing the safety and feasibility of transplantation of GMP-like produced LV-corrected BOECs within an implantable device for the long-term treatment of HA.
Citation
Wragg, N. (2021). Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device. Molecular Therapy - Methods and Clinical Development, 551-566. https://doi.org/10.1016/j.omtm.2021.10.015
Acceptance Date | Oct 29, 2021 |
---|---|
Publication Date | Dec 10, 2021 |
Journal | Molecular Therapy - Methods & Clinical Development |
Print ISSN | 2329-0501 |
Publisher | Cell Press |
Pages | 551-566 |
DOI | https://doi.org/10.1016/j.omtm.2021.10.015 |
Public URL | https://keele-repository.worktribe.com/output/421488 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S2329050121001728 |
Files
PIIS2329050121001728.pdf
(14.5 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc/4.0/
You might also like
The Use of Platelet-Rich Plasma (PRP) for the Management of Non-union Fractures
(2021)
Journal Article
Cryopreservation of Mesenchymal Stem Cells Using Medical Grade Ice Nucleation Inducer.
(2020)
Journal Article
Platelet Rich Plasma as a Treatment Method for Rotator Cuff Tears
(2020)
Journal Article
Development of a 3D Tissue-Engineered Skeletal Muscle and Bone Co-culture System.
(2020)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search